Pain management · 2025
Dopamine agonist treatment normalizes neck motor dyscoordination and relieves pain in chronic tension-type headache and common whiplash. A pilot study.
Клиническое исследование IV фазыСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Astrup Jens, Gyntelberg Finn, Olesen Jes
Аннотация
AIMS: This open-label non-placebo clinical trial was designed as an explorative test of a recent hypothesis suggesting a causative relation between neck muscle dyssynergia and pain in patients with chronic tension-type headache (TTH) and common whiplash (WL). A Dopamine agonist was used as test-treatment. The primary aim was to improve neck muscle dyssynergia and second to observe the effect on pain.
PATIENTS & METHODS: Fifteen patients, comprising 8 tension-type headache and 7 common whiplash patients, all with significant neck muscle tenderness, were started on a standard Pramipexole treatment by 0.18 mg Pramipexole daily and increased by 0.18 mg weekly to 0.18 mg × 3 daily for maintenance. Weekly visits with measurements of head laser tracking (HLT) as indicator of neck muscle dyssynergia, total neck muscle tenderness score, and self-reported daily average headache and neck pain. Head laser tracking was compared to a control group of 8 untreated healthy persons.
RESULTS: HLT normalized during treatment and clinical parameters of pain significantly improved.
CONCLUSION: This result provides preliminary support of the hypothesis of a pathogenetic relation between the dyssynergic neck muscle innervation and pain in TTH and common WL.
CLINICAL TRIAL REGISTRATION: EudraCT 2021-003574-31.
PATIENTS & METHODS: Fifteen patients, comprising 8 tension-type headache and 7 common whiplash patients, all with significant neck muscle tenderness, were started on a standard Pramipexole treatment by 0.18 mg Pramipexole daily and increased by 0.18 mg weekly to 0.18 mg × 3 daily for maintenance. Weekly visits with measurements of head laser tracking (HLT) as indicator of neck muscle dyssynergia, total neck muscle tenderness score, and self-reported daily average headache and neck pain. Head laser tracking was compared to a control group of 8 untreated healthy persons.
RESULTS: HLT normalized during treatment and clinical parameters of pain significantly improved.
CONCLUSION: This result provides preliminary support of the hypothesis of a pathogenetic relation between the dyssynergic neck muscle innervation and pain in TTH and common WL.
CLINICAL TRIAL REGISTRATION: EudraCT 2021-003574-31.